PolarityTE rises on fourth U.S. patent

RegenETP,

17/02/2022 14:22

** Tissue-based treatment developer's  PTE.O  shares rise
4.4% to 47 cent premarket
    ** PTE says https://bit.ly/3uVlB2C the U.S. Patents and
Trademarks Office has issued a U.S. patent for compositions that
relate to co's technology used to develop therapies based on
regenerative tissue 
    ** This is co's fourth U.S. patent
    ** Shares fell as much as ~23% on Aug. 24 after U.S. FDA put
co's application for testing its skin repair product, SkinTE, in
chronic cutaneous ulcers on clinical hold  urn:newsml:reuters.com:*:nL4N2PV2UY
    ** Stock lost ~23.3% this year, as of last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))